Adhesion Barrier Market Size By Product (Synthetic Adhesion Barriers, Natural Adhesion Barriers), By Formulation (Film/Mesh, Gel, Liquid), By Application (General/Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries), & Global Forecast 2024 – 2032

Adhesion Barrier Market Size

Adhesion Barrier Market size was valued at over USD 785.4 million in 2023 and is anticipated to register a CAGR of over 7% between 2024 and 2032. Increase in number of invasive surgical volume, rising geriatric population, and growing awareness related to adhesion related diseases are among the key pointers fueling the industry growth.
 

Rise in number of hospitalization due to post-operative complications coupled with growing R&D activities for development and launch of new adhesion barriers are expected to spur the product adoption rate. For instance, as per the data reported in 2021 by National Healthcare Safety Network, a unit of CDC for tracking healthcare-associated infections (HAIs), there was an increase of around 3% in the surgical site infection standard infection ratio for all operative procedures in 2021.
 

In adhesion barrier market the adhesive diseases represent a notable cause of concern and morbidity especially for patients with post-operative complications. Hence, adhesion barriers are highly recommended and used by surgeons to reduce the complications across different departments such as gynecology, general surgeries, etc.
 

Adhesion barrier is a medical device implant that is used to prevent the formation of internal scarring between organs and internal tissues during the post-surgery period. They are available in gels, physical film/mesh, fabric and in other forms. Adhesion barrier plays a critical role to prevent a patient from post-surgical complications.
 

The development of the adhesion barriers market is being hindered by the reluctance among healthcare professionals to use these products as a preventive measure against postoperative complications. Furthermore, the industry has experienced a few product recalls in recent years due to stringent regulations and approval guidelines. These recalls have created a sense of caution and may dampen the progress of the market during the analysis period.
 

COVID-19 Impact

The recent outbreak of COVID-19 had a negative impact on the adhesion barrier industry revenue in 2020. Several restrictions were imposed across countries globally to avoid the spread of the virus. The COVID-19 pandemic had affected the overall healthcare industry including surgical and treatment modalities. Various factors such as demand and supply shortages due to disruptions in supply-chain logistics, halting of non-emergent healthcare services, and interruptions in surgical procedures significantly impacted the market outlook. Although, the adhesion barriers industry witnessed a notable recovery & an incremental surge in the year-on-year gains trend in the following years.
 

Adhesion Barrier Market Trends

The market is expected to experience growth due to the rising number of sports injuries and traumatic events. Athletes often face post-operative complications, leading to a significant disease burden. The increase in physical and recreational activities has contributed to a surge in sports injuries.
 

For instance, data reported by the National Safety Council (NSC) in 2019 revealed that exercise-related injuries accounted for 468,000 cases, while bicycling-related injuries exceeded 400,000 cases. Sports such as basketball and football contributed to approximately 700,000 injuries. These statistics highlight the prevalence of sports-related injuries, resulting in a higher demand for orthopedic and various surgical procedures.
 

Adhesion Barrier Market Analysis

Based on product, the adhesion barrier market is bifurcated into natural adhesion barriers and synthetic adhesion barriers. The synthetic adhesion barriers segment was valued at around USD 366.4 million in 2022. The high segmental expansion is attributed to availability of robust product portfolio specific to synthetic category including hyaluronic acid, regenerated cellulose, among others. Synthetic adhesion barriers are cost-effective in nature and can hold significant amount of moisture, thus improving the product safety and efficacy. Synthetic barriers are resorbable in nature, thereby eliminating the need for implant removing surgery.
 

Based on formulation, the adhesion barrier market is categorized into film/mesh, gel, and liquid. The film/mesh segment was valued at around USD 281.5 million in 2022. Increasing adoption of film form barriers in different surgeries owing to supportive clinical evidence is projected to fuel the industry revenue. Further, low-cost availability of mesh products with proper safety and efficiency is anticipated to contribute to product adoption over the analysis period. Factors such as ease of use and high adoption of these products by surgeons in comparison to gel and liquid form of barriers is further adding to market demand.
 

Based on application, the adhesion barrier market is segmented into gynecological surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, general/abdominal surgeries, urological surgeries and others. The cardiovascular surgeries segment is anticipated to witness the fastest evolution with a CAGR of 8.2% by 2032. Consistent rise in incidence and prevalence of heart-related disorders is anticipated to spur the adoption of adhesive barriers in cardiovascular surgeries. For instance, as per the data reported by National Heart, Lung, and Blood Institute, over 2 million people have open-heart surgery globally. Additionally, use of adhesion barriers in cardiovascular surgeries prove beneficial in preventing the formation of peristomal adhesion.
 

North America adhesion barrier market is expected to reach around USD 493.5 million in 2032. Presence of significant patient pool related to different diseases including gynecology, neurology, and orthopedic conditions among others is expected to be a key driving factor for regional progression. For instance, as per the data reported by The Johns Hopkins University, around 500,000 hysterectomies are performed each year in the U.S. Moreover, according to the National Institutes of Health data, around 4 million gynecologic surgeries are performed in the U.S. annually.
 

Furthermore, approximately around 7 million orthopedic surgeries are performed in the country. Thus, such high surgical volume necessitates the adoption of adhesive barriers, thereby supporting the market growth. Also, rise in R&D activities for development of technologically advanced novel products is expected to contribute to increased product adoption.
 

Adhesion Barrier Market Share

Some of the leading players operating in the adhesion barrier market include

• Johnson & Johnson
• Baxter International
• Leader Biomedical
• Anika Therapeutics
• Atrium Medical Corporation
• Becton Dickinson and Company
• Integra LifeSciences Holdings Corporation 
   

Adhesion Barrier Industry News:

• In October 2021, Toray Industries, Inc. signed a partnership with ASKA Pharmaceutical Co., Ltd. to develop and commercialize an adhesion barrier product in Japan. As per the agreement, both companies will jointly develop the product and after getting approval, Toray will manufacture, and ASKA will market it exclusively in Japan. This strategic development will help the companies to enhance their product portfolio and increase their business revenue.
   
• In February 2020, Baxter International Inc. announced that it has completed the acquisition of Seprafilm Adhesion Barrier from Sanofi. The deal was completed in USD 350 million. This development will allow the company to expand its global presence in U.S., China, Japan and South Korea among other countries. 
   

Adhesion barrier market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product, 2018 - 2032 (USD Million)

• Synthetic Adhesion Barriers
  • Hyaluronic Acid
  • Regenerated Cellulose
  • Polyethylene Glycol
  • Others
• Natural Adhesion Barriers
  • Collagen & Protein
  • Fibrin

By Formulation, 2018 - 2032 (USD Million)

• Film/Mesh
• Gel
• Liquid

By Application, 2018 - 2032 (USD Million)

• General/Abdominal Surgeries
• Gynecological Surgeries
• Orthopedic Surgeries
• Cardiovascular Surgeries
• Neurological Surgeries
• Urological Surgeries
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Peru
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Israel
  • Iran